Case Study: New Treatment Options for Patients With Chronic Lymphocytic Leukemia
August 2nd 2023With a better understanding of the underlying pathophysiology of chronic lymphocytic leukemia and the introduction of novel targeted agents, such as Bruton kinase Inhibitors, the prognosis of high-risk patients has changed dramatically.
Read More
2 Clarke Drive
Cranbury, NJ 08512